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Abstract
On direct comparison of minimal sets of ordered clones from bacterial arti®cial
chromosome (BAC) libraries representing the complete genomes of Mycobacterium
tuberculosis H37Rv and the vaccine strain, Mycobacterium bovis BCG Pasteur, two
major rearrangements were identi®ed in the genome of M. bovis BCG Pasteur. These were
shown to correspond to two tandem duplications, DU1 and DU2, of 29 668 bp and
36 161 bp, respectively. While DU1 resulted from a single duplication event, DU2
apparently arose from duplication of a 100 kb genomic segment that subsequently incurred
an internal deletion of 64 kb. Several lines of evidence suggest that DU2 may continue to
expand, since two copies were detected in a subpopulation of BCG Pasteur cells. BCG
strains harbouring DU1 and DU2 are diploid for at least 58 genes and contain two copies of
oriC, the chromosomal origin of replication. These ®ndings indicate that these genomic
regions of the BCG genome are still dynamic. Although the role of DU1 and DU2 in the
attenuation and/or altered immunogenicity of BCG is yet unknown, knowledge of their
existence will facilitate quality control of BCG vaccine lots and may help in monitoring
the ef®cacy of the world's most widely used vaccine. Copyright # 2000 John Wiley &
Sons, Ltd.
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Introduction
BCG, the `Bacille de Calmette et Gue Ârin', originally
derived from virulent Mycobacterium bovis, is one
of the oldest and most widely used live vaccines [8].
About 3 billion doses of this attenuated M. bovis
strain have been used to immunize individuals
against tuberculosis worldwide. Although the var-
ious vaccination trials have revealed great varia-
bility in the protective ef®cacy of BCG against
pulmonary disease [11], there is general agreement
that the vaccine is effective against the dissiminated
forms, miliary tuberculosis and tuberculous menin-
gitis [4]. Several hypotheses have been proposed to
explain this variability, ranging from differences in
BCG substrains to environmental and host factors
[4]. Indeed, the history of BCG since the original
attenuation obtained by Calmette and Gue Ârin is
very complex, due to parallel propagation of
different cultures in vitro over a long period,
resulting in genomic modi®cation and adaption to
in vitro growth, which has led to the appearance of
several substrains of BCG [1,2,17].
However, the close relationship of BCG to the
other members of the M. tuberculosis complex,
which share >99.9% identity at the DNA level,
enables us to use the complete genome sequence of
M. tuberculosis H37Rv [9], together with compara-
tive genomics, to elucidate the genetic peculiarities
of M. bovis BCG and its various substrains. The
®rst genomic differences between M. bovis and
M. bovis BCG Connaught were described by
Mahairas et al. [16], using subtractive hybridization
techniques. Their work revealed three genomic
Yeast
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Copyright # 2000 John Wiley & Sons, Ltd.regions (RD1±RD3), which were absent from BCG
but present in M. bovis and M. tuberculosis. Closer
inspection of these deletions showed that RD1 was
consistently absent from all BCG substrains and
present in all strains of M. tuberculosis and M. bovis
tested [16]. In contrast, RD2 was only deleted from
some BCG substrains, while RD3, corresponding to
the prophage phiRv1 [9], was also absent from
several virulent M. bovis isolates [16]. Complemen-
tation of BCG with RD1 has not yet been shown to
restore virulence in the animal model, which
suggests that the BCG attenuation process may
have been more complex than was previously
thought [16]. Further whole genome comparisons
using bacterial arti®cal chromosome (BAC) arrays
[6,12], or DNA microarrays [2], identi®ed several
other differences between M. tuberculosis, M. bovis
and BCG strains. The majority of these deletions
observed in BCG strains were also detected in
M. bovis strains, indicating that they represented
differences between M. bovis and M. tuberculosis,
rather than BCG-speci®c deletions [2,12]. However,
these sophisticated hybridization techniques can
only detect deletions in BCG relative to M.
tuberculosis H37Rv (the template DNA) and can-
not, therefore, identify insertions and chromosomal
rearrangements.
Thus, in an attempt to characterize the genome of
the vaccine strain M. bovis BCG Pasteur 1173P2
more precisely, we have used a complementary
approach to the previously used BAC arrays for
detecting possible insertions and genomic rearran-
gements. This approach is based on pulsed-®eld gel
electrophoresis of HindIII restriction fragments
from selected M. tuberculosis H37Rv and BCG
BACs, covering comparable genomic regions [12].
Using this strategy on a genome-wide basis we
identi®ed two large rearrangements (DU1 and
DU2), which were not detected by other methods
[2,6,12,19], which may have an important impact on
the biology and immunogenicity of the vaccine
strain.
Materials and methods
Bacterial strains and plasmids
The M. tuberculosis complex strains (M. tuberculo-
sis H37Rv, Mycobacterium bovis type strain ATCC
19210) were taken from our laboratory stocks,
while M. bovis BCG substrains (Denmark, Glaxo,
Prague, Russia, Japan) were kindly supplied by
N. Winter and G. Marchal from the BCG labora-
tory, Institut Pasteur, Paris. M. bovis BCG Pasteur
1173P2 was received as a lyophilized vaccine.
Genomic DNA preparation
Preparation of agarose-embedded genomic DNA
from BCG Pasteur was performed as previously
described [5,20]. Plugs were stored in 0.2 M EDTA
at 4uC and washed twice in 50 ml Tris±EDTA
(pH 8)/Triton X-100 (0.1%) at 4uC for 1 h, then
twice in 50 ml restriction enzyme buffer/Triton
X-100 (0.1%) for 1 h at room temperature before
use.
Comparative genomics
Overlapping clones from the M. tuberculosis H37Rv
pBeloBAC11 library [6] and the BCG pBeloBAC11
(HindIII fragments) and pBACe3.6 (EcoRI frag-
ments) libraries [12] were selected on the basis of
their endsequences. BAC DNA from these clones
was prepared from 40 ml cultures, grown in 2r YT
medium containing 12.5 mg/ml chloramphenicol, as
previously described [6]. DNA (100±200 ng) was
digested with HindIII (Boehringer), DraI (Gibco-
BRL) or XbaI (Boehringer) and restriction prod-
ucts separated by pulsed-®eld gel electrophoresis
(PFGE) on a Biorad CHEF II apparatus using a
1% (w/v) agarose gel, and a pulse of 1 s ramped to
1.6 s for 22 h (HindIII) or 1 s to 18 s for 29 h (DraI,
XbaI) at 6 V/cm. Low-range PFGE markers (New
England Biolabs) were used as size standards. Insert
sizes were estimated after staining with ethidium
bromide and visualization with UV light. Agarose
gels were treated by the standard Southern method
and the DNA transferred via capillary blotting to
Hybond-C Extra nitrocellulose membranes (Amer-
sham). DNA was ®xed to the membrane by baking
at 80uC for 2 h. PCR-derived DNA was labelled
with [a-
32P]dCTP using the Prime-It II kit (Strata-
gene), and puri®ed through P10 columns (Biorad)
before use. Hybridizations were performed at 37uC
in 50% formamide, as previously described [20].
Membranes were washed for 15 min at room
temperature in 2r SSC/0.1% SDS, then 1r SSC/
0.1% SDS, and ®nally 0.1r SSC/0.1% SDS. Results
were interpreted from the autoradiograms. Sequen-
cing primers that ¯anked the junction regions were
then designed for PCR and sequencing reactions
with the corresponding BCG BAC used as tem-
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database.
PCR Analysis
Primers used in PCR reactions are listed in Table 1.
Reactions contained 5 mlo f1 0 r PCR buffer
(100 mM b-mercaptoethanol, 600 mM Tris±HCl
pH 8.8, 20 mM MgCl2, 170 mM (NH4)2SO4), 5 ml
20 mM nucleotide mix, 0.2 mM each primer, 10±50 ng
template DNA, 10% DMSO, 0.5 units Taq poly-
merase (Gibco-BRL) and sterile distilled water to
50 ml. Thermal cycling was performed on a PTC-
100 ampli®er (MJ Inc.) with an initial denaturation
step of 90 s at 95uC, followed by 35 cycles of 30 s at
95uC, 1 min at 56uC, and 4 min at 72uC.
Sequencing reactions
Sequencing reactions were performed as previously
described [6]. For clones isolated from the pBelo-
BAC11 library, SP6 and T7 primers were used to
sequence the ends of the inserts, while for
pBACe3.6 clones (XE-clones), vector-derived pri-
mers were used (Table 1). PCR products were
puri®ed prior to sequencing using the QIAquick
PCR puri®cation Kit (QIAGEN). Reactions were
loaded onto 48 cm, 4% polyacrylamide gels and
electrophoresis performed on ABI373A or 377
automated DNA sequencers (Applied Biosystems)
for 10±12 h. Reactions generally gave between
400±700 bp of readable sequence.
Bioinformatics
Sequence data were transferred from the ABI
automated sequencer to DEC-alpha workstations
(Digital) and edited using the TED software from
the Staden package. Edited sequences were com-
pared to the in-house M. tuberculosis database
(H37Rv.dbs) to determine the relative positions
of the end-sequences on the complete genome
sequence. Using this method, the sizes of M.
tuberculosis H37Rv and M. bovis BCG Pasteur
BAC clones were predicted and compared to those
estimated by PFGE analysis of the same clones. In
silico restriction enzyme digestions of selected
genomic regions were performed using the Display
and Analysis programs (DIANA, Artemis) from
the Sanger Centre, Cambridge, UK (available via
http://www.sanger.ac.uk/Software/).
DNA sequence Accession Nos
The nucleotide sequences that ¯ank each junction
region in M. bovis BCG Pasteur have been
deposited at the EMBL database. Accession Nos
for junctions JDU1, JDU2A and JDU2B are
AJ249608, AJ249609 and AJ249610, respectively.
Accession Nos for the dnaA±dnaN spacer region on
clones X592 and X703 are AJ249809 and AJ249810,
respectively. The Accession No. for M. tuberculosis
H37Rv-deleted RvD5 region present in M. bovis
BCG Pasteur (BAC X094) is AJ249811. Informa-
tion on the exact genomic position of the various
BAC clones is available via http://www.pasteur.fr/
recherche/unites/Lgmb/.
Results
Restriction fragment comparison of BAC
With the completion of the genome sequence of M.
tuberculosis H37Rv [9], we have access to an in
silico restriction map of the chromosome of the
Table 1. Primers for PCR and sequencing
Junction DU1
TB16.0F: GAG CCA ACG ATG ATG ATG ACC
TB16.5F: GGT CAC GGT CGG TGT CGT C
TB4398.7R: CAG AAC TGC AGG GGT GGT AC
Junction DU2A
TB3689.5F: CTA GTT GTT CAG CCG CGT CTT
TB3591.0R: ACC GGG GTG TCG GCC AGT T
TB3689.9F: TCG CGG CCA CCG TGC GTA A
TB3591.5R: GGC GCC TAT GAC TGA TAC CC
Junction DU2B
TB3608.0F: GAA CAG GGT CGC GGA GTC T
TB3672.0R: TCG AGG AGG TCG AGT CCT GT
TB3671.7R: GGG TTC ATG AGG TGC TAG GG
RvD5-detection primers
RvD5-intF: GGG TTC ACG TTC ATT ACT GTT C
RvD5-intR: CCT GCG CTT ATC TCT AGC GG
BCG-Pasteur speci®c deletion
Rv1769F: GTGGAGCACCTTGACCTGAT
Rv1769R: CGTCGAATACGAGTCGAACA
Hybridization-probe for DU1
TB4411.0F: CCG GCC ACT CAC TGC CTT C
TB0.3R: ACG GTA GTG TCG TCG GCT TC
Hybridization-probe for DU2 (probe 3675)
TB3675.0F: CCA ACA CCG TCA ACT ACT CGA
TB3675.5R: ATC GCA GAA CTC CGG CGA CA
Sequencing of the dnaA±dnaN region
TB1.2F: CGA TCT GAT CGC CGA CGC C
TB1.5F: TCC GTC AGC GCT CCA AGC G
TB1.8F: GTC CCC AAA CTG CAC ACC CT
TB2.2R: AAT CCG GAA ATC GTC AGA CCG
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terns can be predicted for a given clone, whose end-
sequences are known, and compared with the
experimentally derived restriction pro®le observed
on an agarose gel. However, some of the fragments
may also contain ¯anking vector sequences that
may confound the restriction patterns. To overcome
this, we developed a strategy to directly compare
restriction fragments from M. tuberculosis H37Rv
BAC clones with the corresponding fragments from
BACs harbouring M. bovis BCG Pasteur DNA,
using the same restriction endonuclease (HindIII)
for restriction analysis that was used for the
construction of both BAC libraries [6,12]. As such,
the vector is contained in a single band and the
remaining bands of the pattern correspond to the
restriction fragments of the cloned mycobacterial
insert. This approach allowed direct size compar-
ison of HindIII fragments from partially or fully
overlapping M. tuberculosis H37Rv and BCG
clones and led to the identi®cation of two duplica-
tions in the genome of M. bovis BCG Pasteur.
DU1
DU1 was ®rst observed when the banding pattern
of HindIII digests from BCG BAC clone X038 and
H37Rv-BAC clone Rv13 were compared to each
other. Clones X038 and Rv13 have identical end-
sequences, stretching from the HindIII site at
genomic position 4367 kb via 4412 kb to another
HindIII site at 27 kb, and thus encompass the origin
of chromosomal replication (oriC). In silico analysis
of the HindIII restriction sites for this stretch
revealed one HindIII site at position 4404 kb in
the M. tuberculosis H37Rv genome sequence.
Therefore, the digests of these clones should contain
two large restriction fragments plus the vector-
speci®c band at 8 kb. This was the case for the M.
tuberculosis H37Rv clone Rv13. In contrast, BCG
BAC clone X038 exhibited three bands (plus the
8 kb fragment), two of which were identical to those
obtained from Rv13 (Figures 1 and 2). The
additional band was y29 kb in size. Further
PFGE analysis using the endonuclease DraI
revealed that X038 was indeed 29 kb larger than
Rv13 (data not shown). By PCR screening pools of
BCG BACs using selected oligonucleotides, we
identi®ed three more X-clones covering parts of
this genomic region in BCG: X585, X592 and X703.
End-sequence and PFGE analysis showed that each
clone contained one of the three bands seen in the
X038 digest (Figures 1 and 2).
The end-sequences for the BCG BACs were:
X585 (4367±4404 kb); X592 (4404±4404 kb); and
X703 (4404±27 kb). The puzzling result that clone
X592 had both endsequences in the same genomic
region could be explained by a direct duplication in
BCG and this also gave us an indication of the size
of the rearrangement. Further restriction and
sequence analysis allowed precise identi®cation of
the junction.
PCR with primers corresponding to genomic
positions 16 000 bp and 4 398 700 bp (Table 1)
gave a product of the expected size when clone
X592 or genomic DNA of BCG Pasteur were used
as templates. Direct sequencing of the PCR pro-
ducts and the BAC clone X592 revealed that the
junction was located between positions 16 732 and
4 398 593 relative to the M. tuberculosis H37Rv
genomic sequence, and that this genomic rearrange-
ment resulted in the truncation of genes Rv3910 and
pknB. However, as the rearrangement is a tandem
duplication, intact copies of both genes should be
present in the neighbouring regions. PCR analysis
with ¯anking primers for Rv3910 and pknB con-
®rmed this when genomic DNA from BCG Pasteur
and M. tuberculosis H37Rv were employed (data
not shown).
De®nitive con®rmation of the rearrangement was
obtained by hybridizing a 0.5 kb radio-labelled
probe encompassing the oriC region of M. tubercu-
losis H37Rv to HindIII digests of genomic DNA of
M. tuberculosis, M. bovis and BCG Pasteur. A
single band of y35 kb was detected in the M. bovis
and M. tuberculosis genomes, whereas the probe
hybridized to two DNA fragments, one of which
was 35 kb, and the other 29 kb (Figure 1) when
BCG Pasteur was examined. In summary, DU1
corresponds to a tandem duplication of 29 668 bp
resulting in merodiploidy for the region sigM±pabA
(Rv3911±Rv0013 [9]).
Analysis of the dnaA±dnaN region in strains
with DU1
The dnaA±dnaN region is generally regarded as the
functional origin of replication for mycobacteria
since, on insertion into plasmids lacking their own
origin of replication, the ability to replicate auton-
omously was restored. Evidence for this was ®rst
obtained in M. smegmatis [22] and, more recently,
114 R. Brosch et al.
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diploid for the dnaA±dnaN region, we investigated
whether any nucleotides differed between the two
copies present on the two different BAC clones
X592 and X703 (Figures 1 and 2). Direct sequence
analysis of BAC DNA using ¯anking and internal
primers of dnaA±dnaN intergenic region (Table 1)
revealed no differences between the two copies of
the minimal oriC region. In addition, the sequences
were identical to the one determined by Qin et al.
(Accession No. U75298) for their strain of BCG.
This ®nding suggests that both copies of oriC
should be functional.
Similarly, screening of a BCG Pasteur Tn5367 [3]
transposon library revealed an insertion in one of
the dnaA genes at position 850 bp (E. Wooff, S.
Gordon and R.G. Hewinson, personal communica-
tion). It was initially surprising to ®nd a transfor-
mant harbouring a transposon in dnaA, as this is
normally an essential gene. However, as BCG
Pasteur is diploid for dnaA, the second functional
copy of dnaA could compensate for the loss of dnaA
during transposon mutagenesis.
DU2
The second large genomic rearrangement observed
in the BCG Pasteur chromosome was found on
analysis of several BAC clones, corresponding to
the region between 3550 and 3750 kb, since their
experimentally determined sizes did not agree with
those predicted from endsequence data. Direct
comparisons were complicated by the presence of
an IS6110 element in this region of the M.
tuberculosis H37Rv chromosome that has led to a
small deletion, RvD5 (see below) [7].
Figure 1. Detection of tandem duplication DU1. HindIII digestion of M. tuberculosis H37Rv (Rv) and BCG (X) BAC clones,
M. tuberculosis H37Rv, M. bovis type strain ATCC 19210 and BCG Pasteur genomic DNA and pulsed ®eld gel electrophoresis
(1 s ramped to 2 s over 24 h, 1% agarose gel) reveal an additional genomic fragment of y29 kb in clone X038, not present in
Rv13. Radio-labelled 0.5 kb probe from the oriC genomic region binds to one fragment in M. tuberculosis and M. bovis and to
two fragments in BCG Pasteur. Molecular weight is marked in (kb)
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located around the HindIII site at 3594 kb. PFGE
results showed that the clone was about 106 kb in
size, containing three chromosomal HindIII frag-
ments of 37.5, 37 and 24 kb in addition to the
vector. The 24 kb band was about 2 kb larger than
the corresponding 22 kb HindIII fragment in Rv403
(Figures 3 and 4). This suggested that the genomic
region around 3594 kb might have been duplicated
and that one junction should be near one end of
clone X495. To con®rm this, primer walking was
performed on BAC X495 and a junction, named
JDU2A, was identi®ed between positions 3 690 124
and 3 590 900 relative to the M. tuberculosis H37Rv
genomic sequence (Figure 4). This interrupted the
gene lpdA (Rv3303), but PCR results indicated that
an intact copy is present in the duplicated region
(Figure 4B).
Systematic analysis of other clones in the neigh-
bourhood identi®ed two independent BCG BACs
(X094 and X1026), which carried the same chro-
mosomal segment, 3594±3749 kb. While the end-
sequence data suggested that the clones should be
about 155 kb, size estimation based on PFGE-
separated DraIo rHindIII digestions revealed that
the BACs were only y100 kb in size. This dis-
crepancy indicated that the inserts in clones X094
and X1026 probably extended from the repeated
HindIII sites at 3594 kb to the `authentic' HindIII
site at position 3749 kb (Figure 4), and that an
internal deletion had occurred within the duplicated
unit.
This was con®rmed by hybridization experiments
on HindIII-digested genomic DNA from M. tuber-
culosis H37Rv, M. bovis and BCG Pasteur, using
radiolabelled DNA from clone X495. Figure 3
shows that one of the bands hybridizing in the
HindIII pro®les of M. tuberculosis H37Rv and the
M. bovis type strain was about 22 kb in size, while
the corresponding band in BCG was 24 kb in size,
exactly as seen with the BAC clones. Furthermore,
the hybridization results showed that a band of
34 kb in the HindIII pro®le of clone X094 also
hybridized with genomic DNA from clone X495,
Figure 2. (A) Scheme of the genomic organisation in the corresponding regions encompassing the origin of replication in
BCG Pasteur and M. tuberculosis H37Rv, revealed by BAC mapping, PCR and hybridization experiments. (B) Gene predictions
in the rearranged genomic region DU1 in BCG Pasteur are based on the highly similar M. tuberculosis H37Rv genomic
nucleotide sequence (Accession No. AL123456) and the BAC mapping data. Duplicated regions are indicated by arrows. For
information about predicted gene functions, consult the website http://bioweb.pasteur.fr/GenoList/TubercuList/
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duplicated DNA from the genomic region covered
by X495 (Figures 3 and 4). PCR and DNA
sequencing by primer walking on BAC X094
identi®ed a second junction point, JDU2B, at a
position equivalent to 3 608 471 and 3 671 535 in
M. tuberculosis H37Rv. This con®rmed that DU2
resulted from a direct duplication of the 99 225 bp
region corresponding to the sequences between
positions 3 590 900 and 3 690 124 in the genome of
M. tuberculosis H37Rv, and that an internal
deletion of 63 064 bp then took place. The residual
DU2 unit is thus 36 162 bp in length, consistent
with the mapping data, and BCG Pasteur is diploid
for genes Rv3213c±Rv3230c, and Rv3290c±Rv3302c
[9].
Finally, PCR, PFGE mapping and end-
sequencing experiments with BAC X094 suggested
that BCG Pasteur contained additional DNA in the
chromosomal region of HindIII site 3691±3749.
Direct comparison with the M. tuberculosis H37Rv
BAC clone Rv403 uncovered two extra HindIII
sites in this region, since the HindIII fragment of
48 kb present in Rv403 (corresponding to the
segment 3691±3749; Figure 4), was represented by
two bands of 22 and 36 kb in BCG. This region of
the M. tuberculosis H37Rv chromosome contains a
copy of IS6110 that is not ¯anked by the character-
istic 3 bp direct repeats [13,24]. It is now clear that
there were originally two copies of IS6110 that
served as the substrate for a recombination event.
This resulted in the deletion of a 4 kb segment from
the M. tuberculosis H37Rv genome (RvD5) [7],
which is still present in BCG, as well as in M. bovis
and M. tuberculosis clinical isolates. Sequence
analysis of this region has shown that this 4 kb
fragment contains two HindIII sites (Figure 4) and
lacks the IS6110, which is present at this location in
M. tuberculosis H37Rv. Using internal primers for
RvD5 (Table 1), we obtained amplicons with
Figure 3. Detection of tandem duplication DU2. HindIII digestion of M. tuberculosis H37Rv (Rv) and BCG (X and XE) BAC
clones, M. tuberculosis H37Rv, M. bovis type strain ATCC 19210 and BCG Pasteur genomic DNA and pulsed-®eld gel
electrophoresis (1 s ramped to 2 s over 24 h, 1% agarose gel) reveal restriction fragment polymorphism in BCG- and
M. tuberculosis BAC clones as described in Results. Radiolabelled BAC DNA from clone X495 binds to two fragments in
M. tuberculosis and M. bovis and to three fragments in BCG Pasteur. Molecular weight is marked in kb
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substrains tested, the M. bovis type strain, as well
as with DNA from clones X094 and X1026, but not
from M. tuberculosis strains H37Rv and H37Ra
(data not shown).
Are some BCG cells partially triploid?
On screening 2000 X- and XE-clones [12] for BACs
containing both the JDU2A and the JDU2B
junctions, i.e. which covered the whole rearranged
region, three BACs (X1070, XE377 and XE256)
were identi®ed that produced amplicons with both
sets of primers. Their inserts were estimated to be
y95, 86 and 97 kb in length, respectively, by
PFGE. On the basis of the PCR results, end-
sequence data (corresponding to regions 3632 and
3594 kb), and the presence of three chromosomal
HindIII fragments, of 37, 36, and 24 kb (Figure 5A,
B), we concluded that clone X1070 overlaps clone
X495. However, it contained a 36 kb chromosomal
HindIII fragment which was present in neither
clone X495 nor in clone X094 and, together with
the end-sequence data, this suggested the presence
of a third copy of the HindIII site at 3594 kb in the
rearranged region. Further evidence for this was
obtained when clones XE256 and XE377, isolated
from an EcoRI library in pBACe3.6, were analysed.
According to end-sequence data, XE256 extends
from the EcoRI site at 3597 kb to the EcoRI site at
3713 kb, and XE377 from EcoRI site at 3679 kb to
the EcoRI site at 3715 kb. The fact that these clones
repeatedly yielded amplicons for both junction
regions JDU2A and JDU2B did not agree with
their size and their end-sequences. However, as
shown in Figure 6, these ®ndings were consistent
with the 36 162 bp region DU2 being present as not
only one but two tandem copies. Hybridization of
HindIII-digested DNA from clones XE256, X1070
and XE377 with a 0.5 kb probe from genomic
region 3675 kb con®rmed the PCR results. As
depicted in Figure 5B, one 24 kb fragment of clone
Figure 4. (A) Scheme of the genomic organization in the corresponding regions from 3590 kb to 3755 kb in BCG Pasteur
and M. tuberculosis H37Rv, revealed by BAC mapping, PCR and hybridization experiments. (B) Gene predictions in the
rearranged genomic region DU2 in BCG Pasteur are based on the highly similar M. tuberculosis H37Rv genomic nucleotide
sequence (Accession No. AL123456) and the BAC mapping data. Duplicated regions are shown as boxes. For information
about gene predicted functions, consult the website http://bioweb.pasteur.fr/GenoList/TubercuList/
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and a unique 36 kb fragment, covering an addi-
tional copy of DU2, was also present. Two
fragments of 33 kb and 34 kb from clone XE256
hybridized. The 33 kb fragment corresponds to the
region extending from the HindIII site present in
the vector, adjacent to the EcoRI cloning site, to the
closest HindIII site in the mycobacterial insert,
while the 34 kb fragment was identical to the one
also present in clone X094 (Figures 5B, 6A). The
33 kb fragment overlapped in part clone X1070
while the 34 kb HindIII fragment was identical to
those present in clones X094 and XE377.
These ®ndings indicated that two tandem copies
of DU2 existed in the genome of BCG Pasteur. This
was con®rmed on hybridization of HindIII digests
Figure 5. Detection of a second copy of DU2. (A) HindIII digestion of M. tuberculosis H37Rv (Rv) and BCG (X and XE) BAC
clones and pulsed-®eld gel electrophoresis (1 s ramped to 1.5 s over 24 h, 1% agarose gel) reveals restriction fragment
polymorphism in BCG and M. tuberculosis BAC clones, as described in Results. (B) Radiolabelled 0.5 kb probe from the
genomic region 3675 binds to BCG and M. tuberculosis BAC clone fragments, as described in Results. The hybridization signal
for the two hybridizing fragments in BAC clone X1070 is equally strong. (C) HindIII digestion of BCG Pasteur, M. bovis and
M. tuberculosis H37Rv genomic DNA and pulsed-®eld gel electrophoresis (1 s ramped to 1.5 s over 24 h, 1% agarose gel)
reveals restriction fragment polymorphism in BCG Pasteur, M. bovis and M. tuberculosis H37Rv, as described in Results.
(D) Radiolabelled 0.5 kb probe from the genomic region 3675 binds to one fragment in M. tuberculosis and M. bovis and to
three fragments in BCG Pasteur. The hybridization signals of the corresponding fragments present in the genomic DNA from
BCG Pasteur show a difference in the strength of the signal. Molecular weight is indicated in kb. (E) XbaI digestion of BCG
Pasteur, M. bovis type strain and M. tuberculosis H37Rv genomic DNA and pulsed-®eld gel electrophoresis (1 s ramped to 18 s
over 29 h, 1% agarose gel) reveal different XbaI patterns. BCG exhibits a weak band of y250 kb which is not present in the
pro®les of M. tuberculosis and M. bovis. (F) A radiolabelled 0.5 kb probe from the genomic region 3675 binds to one fragment
in the size range of 183 kb in M. tuberculosis H37Rv and to the corresponding band in M. bovis, which is about 5 kb smaller, as
the number of present IS elements is different. Probe 3675 binds to two fragments in BCG Pasteur, which are y36 or
y72 kb larger than the corresponding 178 kb band in M. bovis, due to the presence of one or two copies of DU2. The
hybridization signal for the 250 kb band is weaker than that of the 215 kb fragment
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losis H37Rv and M. bovis, since these all hybridized
with probe 3675. As expected, only one 22 kb band
was observed with M. tuberculosis and M. bovis,
while three bands of 24, 34 and 36 kb were detected
in the hybridization pattern of BCG Pasteur.
However, as shown in Figure 5D, the hybridization
signal for the 36 kb fragment was very weak. As the
24 and 36 kb bands present in BAC clone X1070
hybridized to probe 3675 with the same intensity
(Figure 5B), whereas those in the genomic DNA of
BCG Pasteur did not (Figure 5D), this suggested
that only a subpopulation of the BCG Pasteur
culture contained the second copy of DU2. Hence,
the difference seen in the intensity of hybridization
may re¯ect the second copy of DU2 having been
gained only recently, and indicates that variants
containing one or two copies of DU2 exist in the
same tube of lyophylized M. bovis BCG Pasteur
1173 vaccine. In order to make sure that the BCG
Pasteur culture in use was not contaminated with
other BCG substrains, which may have accounted
for the extra band observed, we performed PCR
experiments using oligonucleotides (Table 1) that
are speci®c for a genomic region that is absent in
BCG Pasteur 1173, but present in all other BCG
substrains [2]. PCR did not yield any amplicons
with the BCG Pasteur DNA, while controls with
other BCG substrains (Danish, Glaxo) and oligo-
nucleotides from other genomic regions yielded
amplicons of the appropriate sizes (data not
shown).
Further evidence for the presence of the two
variants were obtained when XbaI digests of
genomic DNA from M. tuberculosis, M. bovis,a n d
BCG Pasteur were hybridized with probe 3675
(Figure 5E, 5F). In the M. tuberculosis H37Rv
digest, probe 3675 hybridized to a 183 kb fragment
(genomic position 3646±3829 kb). The correspond-
ing fragment in the M. bovis type strain was
y178 kb and this size difference is due to the
absence of several insertion elements which are only
present in the 183 kb genomic region in M.
tuberculosis H37Rv. The XbaI digest of BCG
Pasteur contained two fragments, of 215 and
250 kb, which hybridized to probe 3675. These
correspond to the 178 kb fragment seen in the M.
bovis genome, increased by either 36 or 72 kb due to
Figure 6. (A) Scheme of the genomic organization in the corresponding regions from 3590 kb to 3755 kb in a subpopulation
of BCG Pasteur containing a second copy of DU2, revealed by BAC mapping, PCR and hybridization experiments. Duplicated
regions are shown as boxes. (B) Scheme of the putative mechanism which led to the appearence of DU2 in BCG Pasteur
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noteworthy that the hybridization signal for the
250 kb fragment was less intense than the signal
obtained with the 215 kb fragment, con®rming
previous observations with HindIII digests. These
®ndings indicate that this region of the BCG
genome is still dynamic and that a subpopulation
of cells are triploid for Rv3213c±Rv3230c, and
Rv3290c±Rv3302c [9].
Screening for duplications in various BCG
substrains
Preliminary PCR and PFGE analyses in various
BCG substrains, using primers JDU1, JDU2A and
JDU2B (Table 1), suggested that DU1 is present
only in BCG Pasteur (data not shown), while DU2
is present in all tested BCG strains but at variable
sizes (data not shown). However, before drawing
more conclusions, a complete set of the various
daughter strains has to be screened for DU1 and
DU2. Analyses of DU1 and DU2 in the other BCG
daughter strains using primers that ¯ank the
junction regions, as well as PFGE comparisons,
are ongoing and will be the subject of a future
publication.
Discussion
The current BCG vaccines are all derived from a
strain of M. bovis that was attenuated by 230 serial
passages on potato-glycerin-ox bile medium [4,8].
Yet, despite decades of use worldwide, the reason
for the attenuation of M. bovis BCG is still
unknown, although comparative genomics is begin-
ning to shed light on some of the possible
mechanisms involved. It has been shown recently,
in whole-genome scans using either BAC arrays [12]
or DNA microarrays [2], that up to 16 genomic
deletions can be found in BCG substrains relative
to M. tuberculosis H37Rv. We are presently
investigating what biological role these deletions
play in terms of virulence and host speci®city. The
fact that most of the end-points of the 16 variable
regions are located inside genes that show homol-
ogy to genes of other organisms suggests that these
regions represent deletions in BCG strains, rather
than insertions in M. tuberculosis.
However, as array techniques are only able to
detect DNA fragments which do not hybridize with
the matrix DNA, duplications or other chromoso-
mal rearrangements cannot be uncovered. Direct
comparison of M. tuberculosis H37Rv- and BCG
BACs thus represents a powerful approach for the
detection of additional genomic differences, and is
providing further insight into genome plasticity as
well as identifying genes and gene products that
may be involved in mycobacterial virulence. In the
present study, the existence of two duplicated
segments of the genome of BCG Pasteur, DU1
and DU2, has been demonstrated.
Inspection of the genome sequence of M. tuber-
culosis H37Rv [9] indicates that BCG Pasteur
should be at least diploid for 58 genes, and that at
one point their common ancestor contained dupli-
cate copies of a further 60 genes that were lost when
the deletion internal to DU2 arose. Tandem
duplications are generally caused by unequal cross-
ing over between homologous sequences, such as IS
elements or rrn operons [15], or by recombination
of short DNA homologies [10].
The mechanism responsible for the duplication of
DU1 and DU2 in M. bovis BCG Pasteur is obscure,
although one can exclude a role for IS elements, as
none is found in these regions of the BCG genome
[9,12]. Furthermore, no highly conserved sequences
could be detected in the corresponding regions of
the M. tuberculosis H37Rv genome [9], as is
probably also the case for M. bovis BCG. The
®nding that DU2 resulted from direct duplication
of a 99 225 bp segment, from which 63 064 bp were
then deleted to leave a residual 36 162 bp fragment,
which was then again duplicated in a subpopulation
of BCG Pasteur, shows how complex duplication
events may be. Dynamic duplication of large
chromosomal sections were also observed in some
strains of Bordetella pertussis (C. Weber, personal
communication), suggesting that tandem duplica-
tions represent an important mechanism for gen-
erating genomic plasticity in other bacteria as well.
Chromosomal duplications provide a means for
increasing gene dosage, for generating novel func-
tions from potential gene fusion events at duplica-
tion endpoints and represent a source of redundant
DNA for divergence. Over half of the proteins
present in the tubercle bacillus have arisen from
ancient gene duplication and adaptation events
[9,23]. The presence of DU1 and DU2, and
particularly the ®nding that DU2 appears to be
present in a subpopulation of BCG Pasteur in two
copies, suggests that the process of tandem duplica-
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source of genome dynamics.
From a practical point of view, the presence of
large repeated regions in the chromosome of M.
bovis BCG underlines the importance of BAC
mapping strategies to accompany genome sequen-
cing, and highlights the potential pitfalls of projects
based solely on sequencing shotgun clones. Without
the BAC resource, it is very likely that the rather
complex genomic rearrangements present in M.
bovis BCG strains would have remained undetected.
Knowledge of large tandem duplications is useful in
interpreting previously published data. As shown in
Figure 5E, a 250 kb band in the XbaI digest of BCG
strains indicates the presence of two copies of DU2
in the genome of BCG. As this band is unique to
BCG, it could be used as a marker for detecting
BCG strains which carry two copies of DU2. When
comparing the XbaI patterns of various BCG
strains shown in previous work by Zhang et al.
[26], it can be noted that the Glaxo and the Danish
BCG strains carried this fragment, while others, like
BCG Tice or BCG Connaught, did not.
DU1 represents a particularly interesting example
of a tandem genetic duplication because it results in
a strain with two copies of oriC, the site of
initiation of chromosomal replication, and genes
encoding key components of the replication initia-
tion and cell division machinery [22]. To our
knowledge, this is the ®rst description of a
bacterium with two oriCs. Multiple copies of oriC
are generally deleterious for the cell, as they can
provoke uncoordinated replication [22]. Although
sequence comparison of the two copies of the
dnaA±dnaN intergenic region, known to be the
functional oriC of M. tuberculosis and BCG [21],
revealed no differences, it is still not known whether
both copies of the BCG Pasteur origin are func-
tional in vivo.
It is probable that increased expression may
result from some of the duplicated or triplicated
genes and lead to phenotypic and immunological
differences. As such effects have been described for
several BCG strains [1,14], and even suggested to
account for variability in vaccine ef®cacy [4,11], it
was of interest to examine the nature of the
sequences present in DU1 and DU2. Among the
known genes in DU1, in addition to those involved
in chromosome replication and cell division, are
coding sequences for DNA gyrase, two tRNAs,
the s-factor, SigM, and a thioredoxin-thioredoxin
reductase system [9]. The last three genes are
particularly noteworthy, since it has been shown in
Streptomyces coelicolor that the SigM counterpart,
SigR, initiates transcription of the adjacent thio-
redoxin system in response to oxidative stress [18].
Furthermore, expression of the Trx system of
Mycobacterium leprae in Mycobacterium smegmatis
renders this avirulent saprophyte resistant to the
oxygen-dependent killing mediated by human
mononuclear phagocytes [25]. Genes located in
DU2 for which probable functions are known
include aroA, encoding 3-phosphoshikimate 1-
carboxyvinyl transferase, a key enzyme in aromatic
amino acid biosynthesis, and the coding sequences
for a variety of regulatory proteins that could exert
pleiotropic effects, including a histidine kinase,
AsnC and TetR homologues, PhoY1, WhiB1, and
another factor, sigma H.
Although at present it is dif®cult to speculate
about the impact of multiple copies of these genes
on the biology, the attenuation process and/or the
immunogenicity of BCG, knowledge of their exis-
tence will facilitate quality control of BCG vaccine
lots and may help in monitoring the ef®cacy of
these vaccines.
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